XNAS:ALIM Alimera Sciences Inc Quarterly Report 10-Q/A Filing - 6/30/2012

Effective Date 6/30/2012

XNAS:ALIM Fair Value Estimate
Premium
XNAS:ALIM Consider Buying
Premium
XNAS:ALIM Consider Selling
Premium
XNAS:ALIM Fair Value Uncertainty
Premium
XNAS:ALIM Economic Moat
Premium
XNAS:ALIM Stewardship
Premium
 
Table of Contents

 

 

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

 

 

Form 10-Q/A

(Amendment No. 1)

 

 

(Mark One)

    x     QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934

For the quarterly period ended June 30, 2012

or

 

    ¨     TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934

For the transition period from          to         

Commission File Number: 001-34703

 

 

Alimera Sciences, Inc.

(Exact name of registrant as specified in its charter)

 

 

 

Delaware   20-0028718

(State or other jurisdiction of

incorporation or organization)

 

(I.R.S. Employer

Identification No.)

 

6120 Windward Parkway, Suite 290

Alpharetta, GA

  30005
(Address of principal executive offices)   (Zip Code)

(678) 990-5740

(Registrant’s telephone number, including area code)

 

 

Indicate by check mark whether the registrant (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days.    Yes  x    No  ¨

Indicate by check mark whether the registrant has submitted electronically and posted on its corporate Web site, if any, every Interactive Data File required to be submitted and posted pursuant to Rule 405 of Regulation S-T (§ 232.405 of this chapter) during the preceding 12 months (or for such shorter period that the registrant was required to submit and post such files).    Yes  x    No  ¨

Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, or a smaller reporting company. See the definitions of “large accelerated filer,” “accelerated filer” and “smaller reporting company” in Rule 12b-2 of the Exchange Act. (Check one):

 

Large accelerated filer   ¨    Accelerated filer   ¨
Non-accelerated filer   x  (Do not check if a smaller reporting company)    Smaller reporting company   ¨

Indicate by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Exchange Act).    Yes  ¨    No  x

As of August 8, 2012, there were 31,432,355 shares of the registrant’s common stock issued and outstanding.

 

 

 


Table of Contents

ALIMERA SCIENCES, INC.

QUARTERLY REPORT ON FORM 10-Q/A

INDEX

 

Explanatory Note

     3   

Item 6. Exhibits

     4   

Signature

     5   

EX-101 INSTANCE DOCUMENT

  

EX-101 SCHEMA DOCUMENT

  

EX-101 CALCULATION LINKBASE DOCUMENT

  

EX-101 LABELS LINKBASE DOCUMENT

  

EX-101 PRESENTATION LINKBASE DOCUMENT

  

 

2


Table of Contents

EXPLANATORY NOTE

The sole purpose of this Amendment No. 1 to the Alimera Sciences, Inc. Quarterly Report on Form 10-Q for the period ended June 30, 2012, filed with the Securities and Exchange Commission (the “SEC”) on August 14, 2012 (the “Form 10-Q”), is to furnish Exhibit 101 to the Form 10-Q in accordance with Rule 405(a)(2) of Regulation S-T. Exhibit 101 consists of the interactive data files that were not included with the Form 10-Q, as allowed by the 30-day grace period for the first quarterly period in which detailed footnote tagging is required.

This Amendment No. 1 does not otherwise change or update the disclosures set forth in the Form 10-Q as originally filed and does not otherwise reflect events, results or developments occurring, or facts that have become known, after the original filing of the Form 10-Q.

Pursuant to Rule 406T of Regulation S-T, the interactive data files contained in Exhibit 101 are not deemed filed or part of a registration statement or prospectus for purposes of Sections 11 or 12 of the Securities Act of 1933, as amended, are deemed not filed for purposes of Section 18 of the Securities Exchange Act of 1934, as amended, and otherwise are not subject to liability under these sections.

 

3


Table of Contents
ITEM 6 Exhibits

 

Exhibit
Number

 

Description

  31.1*   Certification of the Principal Executive Officer, as required by Section 302 of the Sarbanes-Oxley Act of 2002.
  31.2*   Certification of the Principal Financial Officer, as required by Section 302 of the Sarbanes-Oxley Act of 2002.
  32.1*   Certification of the Chief Executive Officer and Chief Financial Officer, as required by Section 906 of the Sarbanes-Oxley Act of 2002.
101.INS**   INSTANCE DOCUMENT
101.SCH**   SCHEMA DOCUMENT
101.CAL**   CALCULATION LINKBASE DOCUMENT
101.LAB**   LABELS LINKBASE DOCUMENT
101.PRE**   PRESENTATION LINKBASE DOCUMENT

 

* Previously filed or furnished, as applicable, as an exhibit to the Alimera Sciences, Inc. Quarterly Report on Form 10-Q (File No. 001-34703) filed with the SEC on August 14, 2012.
** Users of this data are advised pursuant to Rule 406T of Regulation S-T that this interactive data file is deemed not filed or part of a registration statement or prospectus for purposes of Sections 11 or 12 of the Securities Act of 1933, as amended, is deemed not filed for purposes of Section 18 of the Securities Exchange Act of 1934, as amended, and otherwise is not subject to liability under these sections.

 

4


Table of Contents

SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned thereunto duly authorized.

 

    Alimera Sciences, Inc.
   

/s/ C. Daniel Myers

    C. Daniel Myers
   

Chief Executive Officer and President

(Principal executive officer)

September 7, 2012    
   

/s/ Richard S. Eiswirth, Jr.

    Richard S. Eiswirth, Jr.
    Chief Operating Officer and Chief Financial Officer (Principal financial and accounting officer)
September 7, 2012    

 

5


Table of Contents

ALIMERA SCIENCES, INC.

EXHIBIT INDEX

 

Exhibit
Number

 

Description

  31.1*   Certification of the Principal Executive Officer, as required by Section 302 of the Sarbanes-Oxley Act of 2002.
  31.2*   Certification of the Principal Financial Officer, as required by Section 302 of the Sarbanes-Oxley Act of 2002.
  32.1*   Certification of the Chief Executive Officer and Chief Financial Officer, as required by Section 906 of the Sarbanes-Oxley Act of 2002.
101.INS**   INSTANCE DOCUMENT
101.SCH**   SCHEMA DOCUMENT
101.CAL**   CALCULATION LINKBASE DOCUMENT
101.LAB**   LABELS LINKBASE DOCUMENT
101.PRE**   PRESENTATION LINKBASE DOCUMENT

 

* Previously filed or furnished, as applicable, as an exhibit to the Alimera Sciences, Inc. Quarterly Report on Form 10-Q (File No. 001-34703) filed with the SEC on August 14, 2012.
** Users of this data are advised pursuant to Rule 406T of Regulation S-T that this interactive data file is deemed not filed or part of a registration statement or prospectus for purposes of Sections 11 or 12 of the Securities Act of 1933, as amended, is deemed not filed for purposes of Section 18 of the Securities Exchange Act of 1934, as amended, and otherwise is not subject to liability under these sections.

 

6

XNAS:ALIM Alimera Sciences Inc Quarterly Report 10-Q/A Filling

Alimera Sciences Inc XNAS:ALIM Stock - Get Quarterly Report SEC Filing of Alimera Sciences Inc XNAS:ALIM stocks, including company profile, shares outstanding, strategy, business segments, operations, officers, consolidated financial statements, financial notes and ownership information.

XNAS:ALIM Alimera Sciences Inc Quarterly Report 10-Q/A Filing - 6/30/2012
Name |  Ticker |  Star Rating |  Market Cap |  Stock Type |  Sector |  Industry Star Rating |  Investment Style |  Total Assets |  Category |  Top Holdings |  Top Sectors |  Symbol |  Title Star Rating |  Category |  Total Assets |  Top Holdings |  Top Sectors |  Symbol |  Name Title |  Date |  Author |  Collection |  Interest |  Popularity Topic |  Sector |  Key Indicators |  User Interest |  Market Cap |  Industry Name |  Ticker |  Star Rating |  Market Cap |  Stock Type |  Sector |  Industry Star Rating |  Investment Style |  Total Assets |  Category |  Top Holdings |  Top Sectors |  Symbol / Ticker |  Title Star Rating |  Category |  Total Assets |  Symbol / Ticker |  Name Title |  Date |  Author |  Collection |  Popularity |  Interest Title |  Date |  Company |  Symbol |  Interest |  Popularity Topic |  Sector |  Key Indicators |  User Interest |  Market Cap |  Industry Title |  Date |  Company |  Symbol |  Interest |  Popularity

Previous: XNAS:ALIM Alimera Sciences Inc Quarterly Report 10-Q Filing - 6/30/2012  |  Next: XNAS:ALKS Alkermes PLC Annual Report 10-K Filing - 3/31/2012